This report contains market size and forecasts of Hospital Acquired Infections (HAI) Diagnostics in Global, including the following market information:
Global Hospital Acquired Infections (HAI) Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Hospital Acquired Infections (HAI) Diagnostics market was valued at 3428.4 million in 2020 and is projected to reach US$ 4021.5 million by 2027, at a CAGR of 4.1% during the forecast period.
Publisher has surveyed the Hospital Acquired Infections (HAI) Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital Acquired Infections (HAI) Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Type, 2020 (%)
Molecular Diagnostics Tests
Other In-vitro Diagnostic Tests
China Hospital Acquired Infections (HAI) Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Application, 2020 (%)
Bloodstream Infections (BSI)
Urinary Tract Infections (UTI)
Surgical Site Infections (SSI)
Pneumonia
Others
Global Hospital Acquired Infections (HAI) Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Hospital Acquired Infections (HAI) Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Hospital Acquired Infections (HAI) Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Hospital Acquired Infections (HAI) Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
BioM?rieux
Abbott Laboratories
Roche AG
Siemens Healthcare
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hospital Acquired Infections (HAI) Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital Acquired Infections (HAI) Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital Acquired Infections (HAI) Diagnostics Overall Market Size
2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size: 2021 VS 2027
2.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.2 Top Global Hospital Acquired Infections (HAI) Diagnostics Companies Ranked by Revenue
3.3 Global Hospital Acquired Infections (HAI) Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital Acquired Infections (HAI) Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Hospital Acquired Infections (HAI) Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital Acquired Infections (HAI) Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital Acquired Infections (HAI) Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Molecular Diagnostics Tests
4.1.3 Other In-vitro Diagnostic Tests
4.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2027
5.1.2 Bloodstream Infections (BSI)
5.1.3 Urinary Tract Infections (UTI)
5.1.4 Surgical Site Infections (SSI)
5.1.5 Pneumonia
5.1.6 Others
5.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2027
6.3.2 US Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.3.3 Canada Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.3.4 Mexico Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2027
6.4.2 Germany Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.3 France Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.4 U.K. Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.5 Italy Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.6 Russia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.4.8 Benelux Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2027
6.5.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.5.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.5.4 South Korea Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.5.6 India Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2027
6.6.2 Brazil Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.6.3 Argentina Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital Acquired Infections (HAI) Diagnostics Revenue, 2016-2027
6.7.2 Turkey Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.7.3 Israel Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
6.7.5 UAE Hospital Acquired Infections (HAI) Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 BioM
BioM